Standout Papers
Citation Impact
Citing Papers
Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals
2015
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Letrozole in the extended adjuvant setting: MA.17
2007
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
2008
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Knee joint distraction compared with high tibial osteotomy: a randomized controlled trial
2016
Cancer drug resistance: an evolving paradigm
2013 Standout
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis
2013
Epigenetic control of gene expression: Potential implications for cancer treatment
2017
Cancer stem cells revisited
2017 Standout
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Histone deacetylase inhibitors and genomic instability
2008
Epigenetic connections between autoimmune disorders and haematological malignancies
2008
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent
2011
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Neutrophil extracellular traps in immunity and disease
2017 Standout
Epigenetic treatment of solid tumours: a review of clinical trials
2015
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
2008
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
2017
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
The plasticity and stability of regulatory T cells
2013 StandoutNobel
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Leukaemogenesis: more than mutant genes
2009
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
The molecular landscape of head and neck cancer
2018 Standout
Epigenetic modifications and human disease
2010 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Osteoarthritis
2019 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Preservation of Fertility in Patients with Cancer
2009 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Histone deacetylase inhibitors in hematological malignancies and solid tumors
2015
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence
2020
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
2009
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
2009
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
2014
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3‐centered view to an epigenome‐defined view of natural Treg cells
2014 StandoutNobel
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
2010
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Synthesis and biological evaluation of a new series of histone deacetylases inhibitors
2008
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Metallodrugs in Medicinal Inorganic Chemistry
2014
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
2015
Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases
2011
Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
2000
Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
1999
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease
2008
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
N-Hydroxy-7-(2-naphthylthio) Heptanomide Inhibits Retinal and Choroidal Angiogenesis
2009
CCR4 as a Therapeutic Target for Cancer Immunotherapy
2021
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate
2012
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Histone Deacetylase Inhibitors in Cancer Therapy
2009
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
2017
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
2013
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Challenges of Antibacterial Discovery
2011
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Works of Bhupinder Mann being referenced
Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy?
2005
Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy
2006
Can molgramostim enhance the antitumor effects of cytotoxic drugs in patients with advanced sarcomas?
1997
Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
2012
Assessing Non–Cancer-Related Health Status of US Cancer Patients: Other-Cause Survival and Comorbidity Prevalence
2013
Letrozole in the Extended Adjuvant Treatment of Postmenopausal Women with History of Early-Stage Breast Cancer Who Have Completed 5 Years of Adjuvant Tamoxifen
2005
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
2007
Survivorship of high tibial osteotomy in the treatment of osteoarthritis of the knee
2012